Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,672.34
(
-0.65%
)
US TECH 100
24,029.40
(
-0.43%
)
Dow Jones
46,553.62
(
-0.94%
)
Brent Oil
105.57
(
4.88%
)
Bitcoin
71,198.98
(
-3.71%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: investorgold2002 post# 120048

Sunday, 05/15/2011 6:44:22 PM

Sunday, May 15, 2011 6:44:22 PM

Post# of 257253

Are you saying somebody can read this IP and get clues and come up with a different, non-infringing way of making biosimilar?

Clearly, there’s a tradeoff here. Patenting a manufacturing process may have value, but no company wants to show its competitors any more that it has to.

“The notion that there’s a Chinese Wall between sell-side analysts
and investment bankers may be the second-biggest piece of BS
ever promulgated in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now